Skip to main navigation Skip to search Skip to main content

Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins

  • Ludivine Kouton
  • , José Boucraut
  • , Jérome Devaux
  • , Yusuf A. Rajabally
  • , David Adams
  • , Jean Christophe Antoine
  • , Frédéric Bourdain
  • , Alexandre Brodovitch
  • , Jean Philippe Camdessanché
  • , Cécile Cauquil
  • , Jonathan Ciron
  • , Thierry Dubard
  • , Andoni Echaniz-Laguna
  • , Aude Marie Grapperon
  • , Raul Juntas-Morales
  • , Laurent Kremer
  • , Thierry Kuntzer
  • , Céline Labeyrie
  • , Luca Lanfranco
  • , Jean Marc Léger
  • Thierry Maisonobe, Nicolas Mavroudakis, Sylvie Mecharles-Darrigol, Philippe Merle, Jean Baptiste Noury, Violaine Rouaud, Céline Tard, Marie Théaudin, Jean Michel Vallat, Karine Viala, Shahram Attarian, Emilien Delmont*
*Corresponding author for this work
  • University Hospital La Timone
  • La Conception Hospital
  • CNRS Centre National de la Recherche Scientifique
  • Institut de Neurosciences de Montpellier
  • Hôpital Bicêtre
  • Department of Neurology
  • Hôpital Foch
  • Paris-Sud University
  • Université Louis Pasteur
  • Department of Clinical Neurosciences Lausanne University Hospital (CHUV)
  • Department of Nephrology
  • LENA CNRS UPR640 Hopital de la Salpetriere
  • Hôpital Erasme
  • Department of Clinical Neurophysiology
  • A. Calmette Hospital

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: Chronic inflammatory demyelinating polyradiculoneuropathies (CIDP) with antibodies against neurofascin 155 (Nfasc155) or contactin-1 (CNTN1) have distinctive clinical features. Knowledge on their electrophysiological characteristics is still scarce. In this study, we are investigating whether these patients have specific electrophysiological characteristics. Methods: The electrophysiological data from 13 patients with anti-Nfasc155 IgG4 antibodies, 9 with anti-CNTN1 IgG4 antibodies were compared with those of 40 consecutive CIDP patients without antibodies. Results: All the patients with antibodies against Nfasc155 or CNTN1 fulfilled the EFNS/PNS electrodiagnostic criteria for definite CIDP. There was no electrophysiological difference between patients with anti-CNTN1 and anti-Nfasc155 antibodies. Nerve conduction abnormalities were heterogeneously distributed along nerves trunks and roots. They were more pronounced than in CIDP without antibodies. Motor conduction velocity on median nerve <24 m/s or motor velocity on ulnar nerve <26 m/s or motor distal latency on ulnar nerve >7.4 ms were predictive of positive antibodies against the node of Ranvier with a sensitivity of 59% and a specificity of 93%. Conclusions: Marked conduction abnormalities may suggest the presence of positive antibodies against the node of Ranvier. Significance: Anti-Nfasc155 and anti-CNTN1 antibodies target the the paranodal axo-glial domain but are associated with nerve conduction abnormalities mimicking a “demyelinating” neuropathy.

Original languageEnglish
Pages (from-to)921-927
Number of pages7
JournalClinical Neurophysiology
Volume131
Issue number4
Early online date6 Feb 2020
DOIs
Publication statusPublished - 1 Apr 2020

Bibliographical note

Publisher Copyright:
© 2020 International Federation of Clinical Neurophysiology

Keywords

  • CIDP
  • Contactin 1
  • Electrophysiology
  • Neurofascin 155

Fingerprint

Dive into the research topics of 'Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins'. Together they form a unique fingerprint.

Cite this